Have you noticed #vaxxed friends & fam have a whole different #personality since getting #jabbed?
There is a strong #association between #COVID-19 #injections & #neuropsychiatric #disorders.
#Psychosis, 440× more #likely, #Dementia, 140×, #Schizophrenia, 315×.
Kari Bundy

Mirror
t.me/gonzojourney...

Gilgamesh Pharma Successfully Secures $60 Million in Oversubscribed Series A Funding Gilgamesh Pharma has successfully closed a $60 million Series A financing, aimed at advancing innovative neuropsychiatric therapies and capitalizing on its promising pipeline.

Gilgamesh Pharma Successfully Secures $60 Million in Oversubscribed Series A Funding #USA #New_York #Series_A #Neuropsychiatric #Gilgamesh_Pharma

In London for the Functional Genomics in Mental Health workshop to talk about #genetic #preclinical models for #neuropsychiatric disorders, #brain and behavioural development, and the work we are doing within the #MURIDAE cluster of the @mrcmousenetwork.bsky.social

#MHPFGx 🧠🧬🐭📊

Neuropsychiatric Systemic Lupus Erythematosus: A Case Series Neuropsychiatric systemic lupus erythematosus (NPSLE) is a rare and poorly understood manifestation of systemic lupus erythematosus, encompassing a wide range of neurological and psychiatric…

"Each case demonstrated unique #NPSLE manifestations: acute confusional state in the setting of #sepsis, cerebral #vasculitis with retinal involvement, and catatonia.": buff.ly/v6Bdbcj

via @cureusmedical.bsky.social
#MedSky #Lupus #neurology #neuropsychiatric #rheumatology #SLE

From schizophrenia to dementia: Is Cobenfy a potential treatment for behavioral and psychological symptoms of dementia?

Journal of International Medical Research
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#neuropsychiatric #pharmacology #medicine #research #openaccess

Our Seaport team started the year w/a gathering to celebrate the holidays & reflect on our progress last year. It was great to connect as a team & we're excited to carry this energy through 2026 as we continue our mission to serve those impacted by #neuropsychiatric conditions.

Rising #nitrous #oxide misuse among adolescents and young adults is emerging as a serious #neuropsychiatric concern and should be considered in young patients presenting with unexplained psychiatric and atypical cognitive symptoms.

🔗Read more: journals.lww.com/psychopharma...

Neuropsychiatric Systemic Lupus Erythematosus: A Case Series Neuropsychiatric systemic lupus erythematosus (NPSLE) is a rare and poorly understood manifestation of systemic lupus erythematosus, encompassing a wide range of neurological and psychiatric…

"Diagnosing #NPSLE remains complex due to the absence of specific biomarkers & the overlap of symptoms with other #neuropsychiatric conditions. The diagnosis of NPSLE largely remains a #diagnosis of exclusion.": buff.ly/Nv9p15Y

via @cureusmedical.bsky.social
#lupus #Autoimmune #ChronicIllness

The study indicates that post-infection mental illness is driven by a "reciprocal double vulnerability." Existing pro-inflammatory states can predispose individuals to severe infection . #neuropsychiatric #neurocovid sequelae were common from #postcovid with many hospitalised survivors

Transneural Therapeutics Unveils Promising Preclinical Results for TN-001 at ACNP 2026 Transneural Therapeutics has presented encouraging preclinical data for their candidate TN-001, targeting neuropsychiatric disorders, at the ACNP 2026 meeting.

Transneural Therapeutics Unveils Promising Preclinical Results for TN-001 at ACNP 2026 #Bahamas #Nassau #Transneural_Therapeutics #Neuropsychiatric #TN-001

Acid-Suppressive Medication and Neuropsychiatric Disorders This cohort study investigates whether an association between maternal acid-suppressive medication use and the risk of neuropsychiatric disorders exists in children in South Korea.

Exposición a antag rec histaminérgico tipo 2 o inh bomba de protones durante embarazo no se asocia c/mayor riesgo de trast neuropsiquiátricos en la descendencia #acidsuppresor #pregnancy #neuropsychiatric jamanetwork.com/journals/jam...

Childhood maltreatment leaves genetic scars tied to lifelong mental health risks — Medical Xpress A research team led by the Department of Pediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has conducted a pioneering stud...

"...“a pioneering study that established a causal link between childhood maltreatment (CM) and various #neuropsychiatric disorders."
apple.news/ALN_Hg10TRc6... #medsky #childabuse #neurology

#Medsky🧪 #pedsky #immunosky #IDSky#publichealth This study investigates the prevalence & predictive factors of #PostCovid19 #neuropsychiatric symptoms in kids & adolescents .
Highlights
-Adolescents exhibited higher proportions of both non-neuropsychiatric & neuropsychiatric symptoms vs children.

Kids' Neuropsychiatric Events on Montelukast More Common With Psych History Study shows more than four-fold risk in children who already have psychiatric conditions

"They're going to blame the drug if things go wrong, and so I don't want to go down that path." -- John Oppenheimer, MD, on #neuropsychiatric concerns associated with montelukast (Singulair) for #allergy and #asthma treatment in some children. #ACAAI2025
www.medpagetoday.com/meetingcover...

Your anxiety may be controlled by hidden immune cells in the brain Researchers have uncovered surprising evidence that anxiety may be controlled not by neurons but by two dueling groups of immune cells inside the brain. These microglia act like biological pedals—one...

“This is a paradigm shift..It shows that when the brain's #ImmuneSystem has a defect and is not healthy, it can result in very specific #neuropsychiatric disorders."”: buff.ly/kOv3AJk

via sciencedaily
#anxiety #MedSky #brain

Thanks to the NEVYs for nominating us for the Powerhouse Healthcare Company of the Year at the #NEVYs25Awards! Great progress this year w/ the launch of two clinical trials & we look forward to making a difference for those w/ #neuropsychiatric conditions: bit.ly/nevy25

🧠1 BILLION people suffer #Neuropsychiatric disorders! Our study shows #KYNA analogs⛑️protect the #Brain WITHOUT motor side effects🚶‍♂️💡SZR-73 leads the way! @mdpiopenaccess.bsky.social #NeuroScience #BrainHealth #Innovation #DrugDiscovery #MentalHealth
Read & share! www.mdpi.com/2073-4409/14...

these findings suggest that alcohol-related alterations in the #gutbrainaxis may exacerbate #postCOVID #neuropsychiatric outcomes by prolonging systemic & central inflammation. The evidence reviewed throughout this section supports the notion that chronic alcohol consumption

Cannabis and Complex Neuropsychiatric Treatment Increasing evidence has shown that cannabis can help our understanding of neuropsychiatric diseases and shows promise in their treatment as well, especially autism and dementia.

"What has been most striking to me in the diseases listed above is how effective the plants’ components are proving to be, especially in treating those with ASD [Autism] and AD [Alzheimer's]."
#MedicalMarijuana #MedicalCannabis #Marijuana #Cannabis #Autism #Alzheimers #AD #ASD #Neuropsychiatric

Happy Halloween! We had so much fun celebrating together w/ themed team costumes & plenty of laughs. These gatherings remind us how connection energizes our shared commitment to developing new medicines for people living w/ #neuropsychiatric conditions like #depression & #anxiety.

MapLight shares track up after $251m IPO MapLight Therapeutics has made its debut on the Nasdaq, raising $251m for a lead drug that could be a rival to BMS' new schizophrenia drug Cobenfy.

#Neuropsychiatric disorder specialist #MapLightTherapeutics has made its debut on the #Nasdaq, raising $251 million and arriving on the scene valued somewhere north of $800 million.

“We Own It” is a core value of ours & captures our entrepreneurial spirit. Co-Founder & CEO, @daphnezohar.bsky.social, shows us how it's done. Named a Goldman Sachs Most Exceptional Entrepreneur, she inspires us to push boundaries so we can best serve those with #neuropsychiatric conditions.

Association Between COVID-19 Vaccination and Neuropsychiatric Conditions

#mRNA #neurology #psychiatry #neuropsychiatric

ijirms.in/index.php/ij...

#Research

"The severity of #neuropsychiatric symptoms during the acute phase may predict the degree of chronic-phase brain volume alterations. Longitudinal follow-up studies are essential to validate and expand upon these findings"

www.pedneur.com/article/S088...

#LongCovidKids #Paediatric

🎉👏 Congratulations to our #UNIBA team member #ChristianValt whose work has been recognized by the #EEG&ClinicalNeuroscienceSociety with the #YoungInvestigatorAward 2025! 🏆

🧠🔬 He demonstrated significant contributions to translational research in #NeuroPsychiatric #Electrophysiology & #Neuroimaging!

Long-COVID can present with #depression and #anxiety. A novel mindfulness-based #virtual group therapy program may improve #neuropsychiatric symptoms in #LongCOVID and is easily accessible and affordable to most patients. Find out more here: institutionalrepository.aah.org/jpcrr/vol12/...

- Neurological,
- #neuropsychiatric,
- #CVD,
- GIT & musculoskeletal symptoms were also reported with higher prevalence in LC group vs the resolved group (all P <.001).
Patients with LC reported

Leal Therapeutics Secures $30 Million to Advance Novel Neuro-Metabolic Therapies for Critical CNS Disorders Leal Therapeutics has announced a fundraising of $30 million to enhance its innovative approach to treat neurodegenerative and neuropsychiatric disorders with significant unmet needs.

Leal Therapeutics Secures $30 Million to Advance Novel Neuro-Metabolic Therapies for Critical CNS Disorders #United_States #Worcester #Neurodegenerative #Leal_Therapeutics #Neuropsychiatric

🧠1 BILLION people suffer #Neuropsychiatric disorders! Our study shows #KYNA analogs⛑️protect the #Brain WITHOUT motor side effects🚶‍♂️💡SZR-73 leads the way! @mdpiopenaccess.bsky.social #NeuroScience #BrainHealth #Innovation #DrugDiscovery #MentalHealth
Read & share! www.mdpi.com/2073-4409/14...

Hearing Loss, Hearing Aid Use, and Neuropsychiatric Symptoms among Persons Living with Dementia: Findings from NACC Hearing loss is a common comorbidity among persons living with dementia (PLWD), affecting >90% of individuals. Sensory impairments have been associate…

Uso de ayudas auditivas puede reducir el número de síntomas neuropsiquiátricos en pacientes con demencia #hearing #neuropsychiatric #dementia www.sciencedirect.com/science/arti...